David Hulcoop
13 August 2024
Tutorial: Introducing the Open Targets Standalone Deployment ToolManuel Bernal Llinares
2 July 2024
Open Targets Platform 24.06 has been released!Sir Target
19 June 2024
How Ana Cvejic built an immune atlas of lung cancerHelena Cornu
23 May 2024
Integrating pharmacogenetics data: a new lens for target prioritisationIrene López Santiago, April Shen
9 May 2024
Open Targets Platform 24.03 has been released!Sir Target
20 March 2024
Q&A with Lucy Sibbring, an intern with the Open Targets data teamHelena Cornu
29 February 2024
Open Targets Platform 23.12 has been released!Sir Target
30 November 2023
Q&A with Jason Menkiti, an intern with the Open Targets data teamHelena Cornu
8 November 2023
Case study: NCI’s Molecular Targets PlatformAnnalisa Buniello
31 October 2023
Case study: Extracting tidy data from Open Targets Genetics with OtargenHelena Cornu
24 October 2023
Open Targets Platform 23.09 has been released!Sir Target
21 September 2023
Welcome to new Director David HulcoopHelena Cornu
21 September 2023
From hibernation to neurodegeneration: how a cold-resistance protein is paving the way to dementia treatmentsHelena Cornu
15 August 2023
Meet Yakov Tsepilov, our new Genetics team leaderHelena Cornu
7 August 2023
Open Targets Platform 23.06 has been released!Sir Target
26 June 2023
Case study: Open Targets at your fingertips with RaycastHelena Cornu, Irene López Santiago
20 June 2023
Case study: Querying the Open Targets Platform using natural languageHelena Cornu
25 May 2023
Code breaking and the Human Genome ProjectIan Dunham
25 April 2023
A leading scientist in the sequencing of the human genome, Ian Dunham reflects on the early years of the Wellcome Sanger Institute.
How Emmanouil Metzakopian is finding gene targets to treat neurodegenerationHelena Cornu
5 April 2023
Manos Metzakopian discusses his latest research, in which the team validated KAT2B gene knockouts as neuroprotective against ER stress.